All GP articles
-
PHE/DH/DWP guidelineUKHSA management of staff exposure to COVID-19
This summary provides guidance on the management of staff according to COVID-19 exposures, symptoms, and test results
-
PHE/DH/DWP guideline
UKHSA COVID-19 vaccination guidance
A concise summary of guidance for healthcare professionals about the COVID-19 vaccination programme
-
Independent professional body guideline
AWMSG asthma guideline
Core principles of asthma management, inhaler selection and use, and referral guidance, from the All Wales Medicines Strategy Group
-
NICE guideline
NICE cancer recognition and referral guideline
Updated summary of guidance to assist GPs in the recognition of several cancers, and referral to specialist care for further investigation
-
NICE guideline
NICE ‘long COVID’ guideline
Recommendations for identifying and managing ‘long-COVID’ in primary care
-
Independent professional body guideline
FSRH Progestogen-only injectable contraception guideline
Evidence-based recommendations and good practice points for health professionals on the use of progestogen-only injectables available in the UK
-
Independent professional body guideline
FSRH guidance on incorrect use of combined hormonal contraception
This Guidelines summary guides management for when a woman has made a mistake using combined oral contraceptive pills, combined vaginal ring, and combined transdermal patch
-
Independent professional body guideline
GINA strategy 2021: management of asthma
This Guidelines summary outlines recommendations for the management of asthma in adults, adolescents, and children aged 6–11
-
NICE guideline
NICE chronic pain guideline
A summary of guidance to assist healthcare professionals on the diagnosis and management of chronic pain in over 16s
-
NICE guideline
NICE secondary bacterial infection of common skin conditions
This Guidelines summary covers an antimicrobial prescribing strategy for secondary bacterial infection of eczema and covers infection of other common skin conditions
-
NICE guideline
COVID-19 rapid guideline on gastrointestinal and liver conditions affecting immune response
A summary of guidance intended to maximise the safety of children and adults with gastrointestinal or liver conditions treated with drugs affecting the immune response during the COVID-19 pandemic
-
NICE guideline
COVID-19 rapid guideline on dermatological conditions
The purpose of this Guidelines summary is to maximise the safety of children and adults who have dermatological conditions treated with drugs affecting the immune response during the COVID-19 pandemic
-
NICE guideline
COVID-19 guideline on rheumatological autoimmune, inflammatory, and metabolic bone disorders
This guideline aims to maximise the safety of children and adults with rheumatological autoimmune, inflammatory, and metabolic bone disorders during the COVID-19 pandemic
-
Independent professional body guideline
HEART UK Managing hyperlipidaemia and COVID-19
A summary of collated current evidence surrounding the safety of lipid-lowering medications in patients who have COVID-19
-
NICE guideline
NICE CKS on rosacea
A summary of guidance to assist healthcare professionals on the diagnosis and management of rosacea
-
PHE/DH/DWP guideline
PHE MenACWY vaccine guideline
A clear summary of Public Health England's guideline on the meningococcal ACWY immunisation programme for adolescents
-
News
UK government publishes largest ever vaccination delivery plan
The British government has set out a plan that aims to vaccinate millions of people against COVID-19 by the spring
-
News
Moderna COVID-19 vaccine approved by MHRA
The Moderna vaccine has become the third COVID-19 vaccine—and the second mRNA COVID-19 vaccine—to be approved for use in the UK
-
NICE guideline
NICE pancreatitis guideline
Summary of NICE guidance on pancreatitis covers managing complications, nutrition support, and referral for specialist treatment
-
NICE guideline
NICE vitamin D guideline
An up-to-date summary of the recommendations set out in the NICE guideline on increasing vitamin D supplement use among groups at risk of deficiency
